Episode Details
Back to EpisodesCan oral semaglutide reduce heart failure events in patients with heart failure with preserved ejection fraction?
Episode 615
Published 5 months, 2 weeks ago
Description
Oral semaglutide reduced heart failure hospitalizations and cardiovascular death in type 2 diabetes patients with existing heart failure, particularly those with preserved ejection fraction, but showed no benefit in those without baseline heart failure. Modern total hip replacements demonstrate excellent longevity, with over 92% of implants surviving revision-free at 30 years. A pharmacist-led opioid and benzodiazepine tapering program in older adults showed no significant advantage over usual care.